Intrathecal Pemetrexed for SCLC Patients With Refractory Brain Metastases or Leptomeninges Metastatic
Clinical trial NCT06497543 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06497543
- Sponsor
- Hunan Province Tumor Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-01
- Primary completion
- 2025-10-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.